Canal Biotech II
3 rue des satellites
About VectalysVectalys, expert in gene delivery based on lentiviral vectors, is a private biotech company founded by Pascale Bouillé in 2005. Today, Vectalys counts 25 full-time employees exclusively dedicated to providing lentiviral vectors, cell models, molecular biology strategies and supporting your projects. Vectalys aims to help scientists worldwide understand cellular and molecular mechanisms in order to discover new drugs and therapies.
Founder and CEO: Pascale Bouillé
COO: Jan Steuperaert
CAO: Brigitte Mignotte-Darmon
Please click here for Vectalys job opportunities.
Tweets by Vectalys
2 articles with Vectalys
Vectalys and FlashCell Announce Merger to Create Flash Therapeutics, New Gene Therapy Company Based on Lentiviral Platforms and Bioproduction Technologies
Vectalys and FlashCell today announced that they have merged to create Flash Therapeutics.
Desktop Genetics, Vectalys And Horizon Discovery Ltd. Collaborate To Develop And Commercialize Custom-Made CRISPR lenti-gRNA Libraries